Fanconi Anemia with MDS RAEB-2 Rapidly Progressing to AML in a 5-Year-Old Boy
Open Access
- 1 July 2014
- journal article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 30 (1) , 379-382
Abstract
Fanconi’s Anemia is primarily an autosomal recessive genetic disorder characterized by congenital abnormalities, defective haematopoiesis leading to bone marrow failure and increased risk of development of Myelodysplastic syndrome, acute myeloid leukemia and solid tumours. Chromosomal instability can be demonstrated by breakage caused by alkylating agents and forms the basis of diagnosis. Our patient presented with structural deformities associated with features of bone marrow failure in form of pancytopenia. Bone marrow analysis and flow cytometry done on aspirate was suggestive of MDS. He subsequently progressed to frank acute myeloid leukemia and succumbed to the illness. The case is being reported for its rarity especially, Fanconi’s Anemia associated with monosomal karyotype (one monosomy plus one more structural abnormality).Keywords
This publication has 9 references indexed in Scilit:
- Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AMLPediatric Blood & Cancer, 2012
- Pathophysiology and management of inherited bone marrow failure syndromesBlood Reviews, 2010
- Secular Trends in Outcomes for Fanconi Anemia Patients Who Receive Transplants: Implications for Future StudiesTransplantation and Cellular Therapy, 2005
- Fanconi anaemia and leukaemia – clinical and molecular aspectsBritish Journal of Haematology, 2004
- Gene therapy for fanconi anemia.2003
- Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factorBlood, 2003
- A 20-year perspective on the International Fanconi Anemia Registry (IFAR)Blood, 2003
- Cancer in Fanconi anemia, 1927–2001Cancer, 2003
- Fanconi anemia diagnosis and the diepoxybutane (DEB) test.1993